Filter by:
Reset
-
All topics
- All topics
- JSR Life Sciences
- Crown Bioscience
- KBI Biopharma
- MBL
- JSR Corporation
- All years
- All months
JSR launches services firm for biosimilar development
Selexis, Pandion Enter Antibody Service Agreement
Selexis, Tallac to advance novel immunotherapies
Selexis SA and BITT Enter Service Agreement
Crown Bioscience Acquires OcellO
Eurofins DiscoverX Certifies KBI Biopharma
Selexis and KBI to advance Immatics program - BioProcess Insider
KBI Biopharma enters commercial manufacturing deal with AM-Pharma